The Journal of Clinical Psychiatry The Journal of Clinical Psychiatry

The Journal of
Clinical Psychiatry

Empowering mental health professionals with peer-reviewed psychiatric research and insights

Back to top Open menu arrow
Current Issue Archives Authors Reviewers

Page 127

More JCP Articles

JCP
Clinical and Practical Psychopharmacology

December 28, 2016

How do antipsychotics compare to one another in terms of efficacy? Which ones are particularly effective for treatment-resistant patients? In this month’s column, Dr Andrade considers the findings of…
JCP
Letter to the Editor

December 28, 2016

, , , et al
JCP
Letter to the Editor

December 28, 2016

JCP
Original Research

December 28, 2016

Cortical thinning, identified during prodromal Alzheimer’s disease, is a “candidate” biomarker used in clinical therapy trials. This study looked at change in cortical thickness after 1 year of donepezil…
, , , et al
JCP
Original Research

December 28, 2016

Twenty US veterans kill themselves every day. What more can be done to stop this self-slaughter? Dialectical behavior therapy (DBT), which combines behavioral intervention with cognitive techniques of mindfulness,…
, , , et al
JCP
Original Research

December 28, 2016

Understand the association between depression and levels of C-reactive protein (CRP) and fractional exhaled nitric oxide (FeNO).
, ,
JCP
Letter to the Editor

December 28, 2016

, , , et al
JCP
Original Research

December 28, 2016

Cognitive difficulties may be overlooked in treating patients with bipolar or unipolar depression, but 20% of patients report such symptoms. The authors of this article reanalyzed data from 2…
, , , et al
JCP
Original Research

December 28, 2016

, , , et al
JCP
Commentary

December 28, 2016

This commentary by Mark Zimmerman, MD, discusses the article “Generalizability of Neuroimaging Studies in 5 Common Psychiatric Disorders Based on the National Epidemiologic Survey on Alcohol and Related Conditions…
JCP
Meta-Analysis

December 28, 2016

In contrast to depression or anxiety disorders where response is defined as a 50% reduction in symptom severity, a 35% reduction in symptoms is considered to be a response…
, ,
JCP
Article

December 28, 2016

Since older patients are known to be hypersensitive to antipsychotics, are they vulnerable to developing hyperprolactinemia with these drugs? This post hoc study looked at whether the dopamine D2/3…
, , , et al

Watch the New PsychCase360

Explore two real-world schizophrenia cases

Subscribe to read
more articles

Subscribe